BriefCase-Quantification vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Aidoc Medical
VS

AI Verdict

Tool A, BriefCase-Quantification, is designed for radiologists to automate abdominal aortic diameter measurements from CT scans, streamlining imaging workflows. In contrast, Tool B, Eko Low Ejection Fraction Tool (ELEFT), integrates with digital stethoscopes to aid clinicians in the early detection of low ejection fraction during routine physical exams. While both are FDA-cleared cardiology AI solutions, they address different clinical needs and utilize distinct data modalities within the broader cardiac care pathway.

Choose BriefCase-Quantification if…

Choose BriefCase-Quantification if your radiology department requires automated, precise measurements of abdominal aortic diameters from CT scans to enhance diagnostic accuracy and efficiency. This tool is ideal for streamlining workflows in specialties like vascular surgery and cardiology where quantitative analysis of imaging data is critical for clinical decision-making.

View BriefCase-Quantification →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your clinic or practice aims to implement a non-invasive, early screening method for low ejection fraction during routine physical exams. This solution is best suited for primary care physicians, internal medicine, or cardiology practices looking to quickly identify patients at risk for heart failure using digital stethoscopes.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature BriefCase-Quantification Eko Low Ejection Fraction Tool (ELEFT)
Pricing Contact for pricing Unknown
Deployment Cloud-based Unknown
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Low Ejection Fraction Tool (ELEFT)

Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes to provide results in approximately 15 seconds during routine physical exams, offering immediate, non-invasive feedback at the point of care. While BriefCase-Quantification seamlessly integrates into existing radiology workflows, ELEFT's rapid, accessible diagnostic capability during a standard patient encounter provides a higher degree of immediate usability for a broader range of clinicians.

Clinical Value

Eko Low Ejection Fraction Tool (ELEFT)

Both tools are FDA-cleared and offer significant clinical utility. However, ELEFT aids in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams, potentially impacting a larger patient population and enabling earlier intervention for a widespread and serious condition. BriefCase-Quantification provides precise quantitative measurements for specific conditions in radiology, which is valuable but may have a narrower scope of impact compared to early heart failure detection.

Pricing & Value

Tie

Both tools require contacting sales for specific pricing, indicating a lack of public transparency. While BriefCase-Quantification mentions financing options, this is a minor differentiator without concrete pricing details for a direct value comparison. Both are positioned as enterprise solutions, suggesting a significant investment for healthcare organizations.

Enterprise Readiness

BriefCase-Quantification

Both tools are presented as robust enterprise solutions, are cloud-based, HIPAA compliant, have BAAs, and are FDA cleared. However, Aidoc explicitly states that its solutions, including BriefCase-Quantification, are 'live in more than 1,600 hospitals', demonstrating a proven track record of widespread enterprise deployment and adoption that is not explicitly detailed for Eko's SENSORAu2122 platform in the provided information.

Innovation

Eko Low Ejection Fraction Tool (ELEFT)

BriefCase-Quantification innovates by automating precise quantitative measurements within radiology workflows. ELEFT, however, integrates sophisticated AI diagnostics with a common, non-invasive medical device (digital stethoscope) for early detection of a critical condition at the point of care during routine physical exams. This approach represents a more innovative application of AI in democratizing advanced diagnostics in primary care settings.

Support & Docs

Tie

Both companies appear to offer robust support and documentation. Aidoc emphasizes a 'customer success' team providing training and performance tracking, while Eko Health provides a comprehensive online Help Center with FAQs, guides, user manuals, and multiple contact options, including a dedicated portal for enterprise customers. Without specific comparative metrics on the quality or responsiveness of support, it is difficult to distinguish a clear winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature BriefCase-Quantification Eko Low Ejection Fraction Tool (ELEFT)
Product Name BriefCase-Quantification Eko Low Ejection Fraction Tool (ELEFT)
Company Aidoc Medical Eko Health
Description FDA-cleared AI tool for radiologists, providing automated abdominal aortic diameter measurements from CT scans to assist clinical decision-making and streamline workflows. FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Primary Function Automated abdominal aortic diameter measurement AI-powered low ejection fraction detection
Key Specialties Cardiology, Radiology, Vascular Surgery Cardiology, Family Medicine, Internal Medicine
Integration Integration with image review software, Part of Aidoc's aiOSu2122 enterprise AI platform Integrates with FDA-cleared Eko digital stethoscopes, Part of the SENSORAu2122 Cardiac Early Detection Platform

Videos

Demos, reviews, and walkthroughs featuring BriefCase-Quantification and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Aidoc's BriefCase-Quantification is an FDA-cleared AI tool for radiologists, providing automated abdominal aortic diameter measurements from CT scans to assist clinical decision-making and streamline workflows. The Eko Low Ejection Fraction Tool (ELEFT) is an FDA-cleared AI algorithm that aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
BriefCase-Quantification analyzes CT scans to provide quantitative measurements of abdominal aortic diameter. Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes to analyze ECG and heart sound recordings.
BriefCase-Quantification integrates with image review software and is part of Aidoc's aiOSu2122 enterprise AI platform, supporting streamlined radiological workflows. ELEFT integrates with FDA-cleared Eko digital stethoscopes as part of the SENSORAu2122 Cardiac Early Detection Platform, designed for use during routine physical exams.
BriefCase-Quantification primarily supports Cardiology, Radiology, and Vascular Surgery. Eko Low Ejection Fraction Tool (ELEFT) is designed for Cardiology, Family Medicine, and Internal Medicine.
The Eko Low Ejection Fraction Tool (ELEFT) provides results in approximately 15 seconds. The provided information for Aidoc's BriefCase-Quantification does not specify a processing time for its measurements.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.